Synthesis of some new biheterocyclic triazole derivatives and evaluation of their antimicrobial activity

2-{3-(4-Substitutedbenzyl)-4-[2-(1H-indol-3-yl)ethyl]-5-oxo-4,5- dihydro-1H-1,2,4-triazol-1-yl}-N'-(aryl-methylene)acetohydrazides (5a-g), 4-amino-2-{-(4-substitutedbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol- 1-yl}-N'-(arylmethylene)acetohydrazides (6a,b), and 4-[2-(1H-indol- 3-yl)ethyl]-5-(4-substitutedbenzyl)-2-{5-(phenylamino)-1,3,4-thiadiazol- 2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-ones (8a,b) were synthesized starting from 4-alkyl-5-(4-substitutedbenzyl)-2,4-dihydro- 3H-1,2,4-triazol-3-ones (2a-c) by several steps and their structures were well characterized by elemental analyses, IR, 1H-NMR, 13C-NMR, and mass spectral studies. They were also screened for their microbial activities. The obtained antimicrobial activity results revealed that 12 among the 24 compounds tested displayed variable growth inhibition effects on the tested gram-positive and gram-negative bacterial strains. None of the compounds showed antifungal activity against yeast-like fungi.

Synthesis of some new biheterocyclic triazole derivatives and evaluation of their antimicrobial activity

2-{3-(4-Substitutedbenzyl)-4-[2-(1H-indol-3-yl)ethyl]-5-oxo-4,5- dihydro-1H-1,2,4-triazol-1-yl}-N'-(aryl-methylene)acetohydrazides (5a-g), 4-amino-2-{-(4-substitutedbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol- 1-yl}-N'-(arylmethylene)acetohydrazides (6a,b), and 4-[2-(1H-indol- 3-yl)ethyl]-5-(4-substitutedbenzyl)-2-{5-(phenylamino)-1,3,4-thiadiazol- 2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-ones (8a,b) were synthesized starting from 4-alkyl-5-(4-substitutedbenzyl)-2,4-dihydro- 3H-1,2,4-triazol-3-ones (2a-c) by several steps and their structures were well characterized by elemental analyses, IR, 1H-NMR, 13C-NMR, and mass spectral studies. They were also screened for their microbial activities. The obtained antimicrobial activity results revealed that 12 among the 24 compounds tested displayed variable growth inhibition effects on the tested gram-positive and gram-negative bacterial strains. None of the compounds showed antifungal activity against yeast-like fungi.

___

  • Ram, V. J. J. Het. Chem. 1998, 2, 253-256.
  • Yu, D.; Huiyuan, G. Bioorg. Med. Chem. Lett. 2002, 12, 857-859.
  • Bonde, C.; Gaikwad, N. J. Bioorg. Med. Chem. 2004, 12, 2151-2161.
  • Koca, M.; Servi, S.; Kirilmis, C.; Ahmedzade, M.; Kazaz, C.; ¨Ozbek, B.; ¨Ot¨uk, G. Eur. J. Med. Chem. 2005, 40, 1358.
  • Sbardella, G.; Mai, A.; Artico, M.; Loddo, R.; Setzuc, M. G.; La Collac, P. Bioorg. Med. Chem. Lett. 2004, 14, 1541.
  • Karalı, N.; G¨ursoy, A.; Kandemirli, F.; Shvets, N., Kaynak, F. B.; ¨Ozbey, S.; Kovalishyn V.; Dimogloc, A. Bioorg. Med. Chem. 2007, 15, 5888-5904.
  • Leboho, T. C.; Michael, J. P.; van Otterlo, W. A. L.; van Vuuren, S. F.; de Koning, C. B. Bioorg. Med. Chem. Lett. 2009, 19, 4948-4951.
  • Kutschy, P.; Mojmir, S.; Andreani, A.; Dzurilla, M.; Kov´acik, V.; Alf¨odi J.; Rossi, M.; Gramatov´a, M. Tetrahedron , 58, 9029-9039.
  • Ryu, C. K.; Lee, J. Y.; Park, R. E.; Ma, M. Y.; Nho, J. H. Bioorg. Med. Chem. Lett. 2007, 17, 127-131.
  • Samosorn, S.; Bremner, J. B.; Ball, A.; Lewis, K. Bioorg. Med. Chem. 2006, 14, 857-865.
  • Kaplancıklı, Z. A.; Turan-Zitouni, G.; ¨Ozdemir, A.; Revial, G. Eur. J. Med. Chem. 2008, 43, 155-159.
  • K¨u¸c¨ukg¨uzel, S. G.; Rollas, S.; Erdeniz, H.; Kiraz, M. Eur. J. Med. Chem. 1999, 34, 153-160.
  • Y¨uksek, H.; Demirba¸s, A.; Ikizler, A.; Johansson, C. B.; C¸ elik, C. Ikizler, A. A. Arzn.-Forsh. Drug Res. 1997, 47, 409.
  • Tozkoparan, B.; G¨okhan, N.; Aktay, G.; Ye¸silada, E.; Ertan, M. Eur. J. Med. Chem. 2000, 35, 743-750.
  • Ikizler, A. A.; Uzunali, E.; Demirba¸s, A. Indian J. Pharm. Sci. 2000, 5, 289-292.
  • Demirbas, N.; Ugurluoglu, R.; Demirbas, A. Bioorg. Med. Chem. 2002, 10, 3717-3723.
  • Turan-Zitouni, G.; Sıvacı, M.; Kılı¸c, F. S.; Erol, K. Eur. J. Med. Chem. 2001, 36, 685-689.
  • Demirbas, A.; Johansson, C. B.; Duman, N.; Ikizler, A. Acta Pol. Pharm.-Drug Res. 1996, 53, 117-123.
  • Ikizler, A.; Demirbas, N.; Ikizler, A. A. J. Het. Chem. 1996, 33, 1765-1769.
  • Malbec, F.; Milcent, R.; Vicart ,P.; Bure, A. M. J. Het. Chem. 1984, 21, 1769-1774.
  • Zhang, J.; Chang, C-W. T. J. Org. Chem. 2009, in press.
  • Goss, P. E. Best Practice Res. 2004, 18, 113-130.
  • Yu, L. T.; Ho, M. T.; Chang, C. Y. and Yang, T. K. Tetrahedron: Asim., 2007, 18, 949-962.
  • Gupta, A.; Unadkat, J. D. and Mao, Q. J. Pharm. Sci. 2007, 96, 3226-3235.
  • Schiller, S. D. and Fung, H. B.; Clinical Therapeutics 2008, 29, 1862-1886.
  • Ashok, M.; Holla, B. S. and Poojary, B., Eur. J. Med. Chem. 2007, 42, 1095-1101.
  • Rao, B. M.; Sangaraju, S.; Srinivasu, M. K.; Madhavan, P.; Devi, M. L.; Kumar, P. R.; Candrasekhar, P.; Arpitha, Ch.; Balaji, T. S. J. Pharm. Biomed. Anal. 2006, 41, 1146-1151.
  • Hancu, G.; Gaspar, A.; Gyeresi, A. J. Biochem. Biophys. Methods 2007, 69, 251-259.
  • Bajetti, E.; Zilembo, N.; Bichisao, E.; Pozzi, P.; Toffolatti, T. Critical Reviews in Oncology: Hematology 2000, 33, 142.
  • Holla, B. S.; Shivananda, M. K.; Shenoy, M. S.; Antony, G. Il Farmaco 1998, 53, 531-535.
  • Holla, B. S.; Mahalinga, M.; Karthikeyan, M. S.; Poojary, B.; Akberali, P. M.; Kumari, N. S. Eur. J. Med. Chem. , 40, 1173-1178.
  • Holla, B. S.; Rao, B. S.; Shridhara, K.; Akberali, P. M. Il Farmaco 2000, 55, 338-344.
  • Holla, B. S.; Veerendra, M. K. Shivananda, B. Poojary, B. Eur. J. Med. Chem. 2003, 38, 759-767.
  • Ashok, M.; Holla, B. S.; Poojary, B. Eur. J. Med. Chem. 2007, 42, 1095-1101.
  • National Committee for Clinical Laboratory Standards 1993. NCCLS Document M7-A3, 13, (25), Willanova, PA., USA.
  • Milcent, R.; Redeuilh, C. J. Het. Chem. 1979, 16, 403-407.
  • Demirbas, N.; Demirbas, A., Karaoglu, S. A.; C¸ elik, E. Arkivoc 2005, (i ), 75-91.
  • Bayrak, H.; Demirbas, A.; Demirbas, N.; Alpay-Karaoglu, S. Eur. J. Med. Chem. 2009, 44, 1057-1066.
  • Demirbas, A.; Sahin, D.; Demirbas, N.; Alpay-Karaoglu, S. Eur. J. Med. Chem. 2009, 44, 2896-2903.
  • Demirbas, N.; Karaoglu, S. A.; Demirbas, A.; Sancak, K. Eur. J. Med. Chem. 2004, 39, 793-804.
  • Demirba¸s, A. Turk. J. Chem. 2004, 28, 311-323.
  • Galic, N.; Peric, B.; Kojic-Prodic, B.; Cimerman, Z. J. Mol. Stuc. 2001, 559, 187-194.
  • Wyrzykiewicz, E.; Prukah, D. J. Het. Chem. 1998, 35, 381-387.
Turkish Journal of Chemistry-Cover
  • ISSN: 1300-0527
  • Yayın Aralığı: 6
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Direct reductive amination of carbonyl compounds using sodium borohydride-silica chloride

Direct reductive amination of carbonyl c Sodium

Performance evaluation of platinum-based catalysts for the development of proton exchange membrane fuel cells

Performance evaluation of platinum-based Development

Inclusion and release of theophylline from chitosan based microparticles

Inclusion and release of theophylline fr Microparticles

Synthesis and characterization of non-symmetric tetradentate complexes of Zn(II), Co(II), and Cu(II)

Synthesis and characterization of non-sy Of

Highly stereoselective and efficient synthesis of the dopa analogue in pepticinnamin E via enantioselective hydrogenation of dehydroamino acids

Highly stereoselective and efficient syn In

Composition of the essential oils of Pinus nigra Arnold from Turkey

Composition of the essential oils of Pin Turkey, Ekrem SEZİK, Osman ÜSTÜN, Betül DEMİRCİ, K. Hüsnü Can BAŞER

Synthesis, structural determination, and biological activity of new 7-hydroxy-3-pyrazolyl-4H-chromen- 4-ones and their o-β-D-glucosides

Vijay TAILE, Kishor HATZADE, Pravin GAIDHANE, Vishwas INGLE

Synthesis of some new biheterocyclic triazole derivatives and evaluation of their antimicrobial activity

Synthesis Of Some New Biheterocyclic Tri AND

Synthesis and antimicrobial activity of N-alkyl substituted p-methyl (E)-3- and 4-azachalconium bromides

Synthesis and antimicrobial activity of Substituted, Nurettin YAYLI, Gülbin MISIR, Nuran YAYLI, Ahmet YAŞAR, Emine DEMİR, Zihni DEMİRBAĞ

Stabilizing cyclacene molecules

Stabilizing cyclacene Molecules